
Mitchell L. Shiffman, MD, reviews the most clinically relevant new data on the management of HCV presented at the meeting.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss data on the natural history of hepatitis C after SVR
- Describe results from recent studies that seek to define tailored therapy for those with hepatitis C genotype 1 infection
- List strategies for the retreatment of nonresponders
- Recount information about new treatments for chronic hepatitis C infection